share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

SEC announcement ·  Mar 12 09:43
Summary by Futu AI
On March 7, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc, completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 28,890 shares of Novavax common stock. On the same day, he sold 13,955 shares at a price of $5.61 per share, resulting in a total market value of $78,287.55 for the disposed shares. Following these transactions, Trizzino's direct holdings in Novavax amounted to 25,590 shares.
On March 7, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc, completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 28,890 shares of Novavax common stock. On the same day, he sold 13,955 shares at a price of $5.61 per share, resulting in a total market value of $78,287.55 for the disposed shares. Following these transactions, Trizzino's direct holdings in Novavax amounted to 25,590 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.